Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-25-001971
Filing Date
2025-01-08
Accepted
2025-01-08 13:01:34
Documents
19
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K ea0227013-10ka2_rafael.htm   iXBRL 10-K/A 629532
2 CERTIFICATION ea022701301ex31-01_rafael.htm EX-31.01 9389
3 CERTIFICATION ea022701301ex31-02_rafael.htm EX-31.02 9376
4 CERTIFICATION ea022701301ex32-01_rafael.htm EX-32.01 4247
5 CERTIFICATION ea022701301ex32-02_rafael.htm EX-32.02 4182
  Complete submission text file 0001213900-25-001971.txt   1017586

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rfl-20240731.xsd EX-101.SCH 3285
7 XBRL DEFINITION FILE rfl-20240731_def.xml EX-101.DEF 17523
8 XBRL LABEL FILE rfl-20240731_lab.xml EX-101.LAB 34517
9 XBRL PRESENTATION FILE rfl-20240731_pre.xml EX-101.PRE 18128
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0227013-10ka2_rafael_htm.xml XML 6882
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 001-38411 | Film No.: 25517584
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)